Status:
COMPLETED
Anemia in Patients With Endocarditis
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Anemia
Endocarditis, Bacterial
Eligibility:
All Genders
18+ years
Brief Summary
Prospective study of prevalence and deep charecterization of anemia in patients with endocarditis from diagnosis undtill 6 months after discharge.
Detailed Description
Anemia is an adverse prognostic marker in both cardiac diseases and infectious diseases. In patients with bacterial endocarditis (IE), anemia has a prevalence of 55-80%. In a sub-study to our POET I t...
Eligibility Criteria
Inclusion
- IE-patients:
- • Infectious endocarditis, defined by Duke criteria
Exclusion
- • Known rheumatic disease or immune defect
- TAVI/TEVAR patients:
- Inclusion Criteria:
- • Scheduled for a TAVI/TEVAR procedure
- Exclusion criteria:
- Clinical suspicion of infection
- Known rheumatic disease or immune defect
- Bacterial patients without IE (short infection):
- Inclusion criteria
- Patients admitted with an infection with gram positive bacteria, without IE Exclusion criteria
- Known rheumatic disease or immune defect
- Blood donors:
- Exclusion criteria:
- Antibiotic treatment within the last 2 months
- Cancer, rheumatic disease or other known inflammatory disease
- Surgery within the last 3 months
- Pregnancy
Key Trial Info
Start Date :
March 22 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 29 2023
Estimated Enrollment :
209 Patients enrolled
Trial Details
Trial ID
NCT04840225
Start Date
March 22 2021
End Date
June 29 2023
Last Update
September 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet
Copenhagen, Denmark, 2100